NXSTAGE PUREFLOW SOLUTION RFP-209-CAN

nxstage medical inc🇨🇦 Health Canada

Approval Id: c170650307aab7d5
Drug Approval Canada Name: NXSTAGE PUREFLOW SOLUTION RFP-209-CAN
Product Name: NXSTAGE PUREFLOW SOLUTION RFP-209-CAN
Status: Marketed
Status Date: 2016-09-15
Original Market Date: 2016-09-15
Din: 02443295
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Haemodialysis
Schedule: Ethical
Ahfs: 40:34.00*
Atc Original: B05ZA HEMODIALYTICS, CONCENTRATES
Atc Name: b 05 za
Aig Number: 0633087010
Company Name: nxstage medical inc
Company Address: 350 Merrimack Street, Lawrence, Massachusetts, United States, 01843

DEXTROSE

1.1 G / L

CALCIUM CHLORIDE

0.221 G / L

MAGNESIUM CHLORIDE

0.102 G / L

POTASSIUM CHLORIDE

0.15 G / L

SODIUM LACTATE

8.408 G / L

SODIUM CHLORIDE

5.552 G / L

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c170650307aab7d5

Type

Standard